I'm leaning with an entity that has an ag component. Would not have said this a month ago, but recent patent is really good. jmho.
The link article looks really encouraging - go to the mblx twitter feed for the link and pswd. I'm not being Pollyanna but the medical textile thing is a head turner. Hospitals generate tons of single use gown and fabric waste.
"By improving the softness characteristics of PLA nonwovens, expanded potential is possible in medical, personal hygiene (where skin contact comfort is important) and home care applications where single use is expected. The PHA modifier doesn’t compromise the 100% renewable makeup of these non-woven single-use materials.
In textiles, touch and feel comparable to PET is also an important aesthetic factor for success and PHA copolymer modifiers can enable this softness in PLA filaments (Fig. 4). Furthermore, being polyesters in their backbone chemistry, PHA modifiers are compatible with typical fiber treatments for dying and sizing.
•Distinct Advantages of PHA modifiers in PLA fibers
•Efficient improvement of touch and feel
•Compatibility with fiber treatments
•100% Renewable (bio-based)
Metabolix is prototyping these PHA modifiers on a pilot scale in nonwoven and monofilament applications and expects to launch several modifier Masterbatches this year and into 2015 when expanded production of the new PHA copolymer products is expected to be available. These products will take advantage of the extended range of PHA copolymer technology that Metabolix has developed and a variety of PLA base resins to provide solutions for expanding the market potential of PLA fibers".
Not sick at all - but then again I don't foolishly shove All-In such that I'm forced to make emotional decisions clouded by anger. I hope you've reflected on this experience and come out the better for it. As I've said before, I've taken this ride and while it's wrenching, patience and allocation rule all. I rode ACAS back from 0.90 to a tidy profit after being down, gulp +90%, and followed EXAS from, get this, 0.37 in '08 - I started buying in '11 and I'm almost at a double with a cost basis of 9.7x. Of course reasoning like this is no resigning at all, but after watching and experiencing sub 1.00 depth charges, this is but another curious learning and investing experience.
Well it appears trading is halted - or is it a yahoo thing. Next sound could be toilet flush or fireworks.
Unquestionably there will be news today. fwiw no online chatter about layoffs or folks sending out resumes (not that my search is exhaustive).
I've been shaking the trees trying to get someone with a good ag-biz and science background to put some critical eyes on their most recent patent app. From my knowledgable but ag limited science perspective it seems incredibly noteworthy and, I think would add substantial value to any sale were it to occur. jmho. best to all
It's about the spectrum and the eq to service it. Sprint/Softbank bought the largest chuck of gigahertz spectrum remaining. The telco deals are all about spectrum and gigahertz gives one video power.
do you have any idea how much foreign dan you consume daily?? please provide a citation so that this can be examined.
patent application. It seems rather eyebrow raising but I'd like some critical eyes on it.
I think folks here will find it worth their time.
WO2014100289 TRANSCRIPTIONAL REGULATION FOR IMPROVED PLANT PRODUCTIVITY
0009] Screening of a number of transcription factor candidates has resulted in the identification of novel transcription factors that when expressed from a heterologous promoter in transgenic plants results in plants having increased expression of these
transcription factors. The increased expression levels can be up to 1.2 fold 1.3 fold, 1.5 fold, 2 fold, 3 fold, 4 fold, 5 fold, 6 fold, 7 fold, 8 fold, a 9 fold or greater than 10 fold the level of background expression found in a wild-type plant (e.g., non-transgenic plant, test plant or control plant). As a result of the increased expression of these transcription factors a number of beneficial traits are achieved including but not limited to: increased levels of photosynthetic pigments; increased photosynthetic capacity; increased levels of nonstructural carbohydrates, including starch, sucrose and glucose in plant tissues; increased levels of fatty acids in plant tissues; increased biomass growth rate and yield; and improved stress tolerance in comparison to wild- type plants. Methods for identifying transcription factors and producing the transgenic plants are also described herein. The transcription factor genes, their homologs and/or orthologs and the methods described herein for increasing their expression or for expressing them in heterologous hosts can achieve yield improvements in a wide range of crop plants.
 In a ninth aspect or of any of the embodiments of the first aspect, the transgenic plant of the first aspect has a starch content (e.g., yield) increased by at least 2 fold greater than the corresponding starch content of a non-transgenic plant.
 In a tenth aspect or of any of the embodiments of the first aspect, the transgenic plant of the first aspect has a starch content of at least 2 fold greater to about 4.3 greater than the content of a non-transgenic plant.